Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Alexa can now securely transmit and receive personalized medical information.
WHO estimates that 170 million people are chronically infected with hepatitis C globally, and 347 million have diabetes.
Interestingly, the drugs themselves, not just the act of curing the virus, were tied to a lower diabetes risk in a recent large study.
Non-alcoholic fatty liver disease can lead to more severe, potentially fatal liver diseases, including cirrhosis.
However, while HbA1c and fasting glucose levels decline after a hep C cure, the clinical significance of such shifts remains unclear.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
Conditions such as autoimmune disorders, insulin resistance and cardiovascular disease tend to have a better outlook.
This is according to an analysis of multiple factors potentially related to a diabetes diagnosis in a large group of French people with HIV.
This is according to an analysis of nearly 5,000 Italians recently treated for the virus.
Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.
Neither age nor body weight were significantly associated with type 2 diabetes among older people with HIV in a recent study.
Among the hep C population, other factors associated with chronic kidney disease include being older and having diabetes or HIV.
And can treating the virus reduce the risk of chronic kidney and cardiovascular diseases as well as the risk of death from such causes?
This finding calls into question the importance of the one differentiation between alcoholic and non-alcoholic fatty liver disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.